An Overview of the Pathophysiological Mechanisms of 3-Nitropropionic Acid (3-NPA) as a Neurotoxin in a Huntington's Disease Model and Its Relevance to Drug Discovery and Development

No Thumbnail Available

Date

2023-02-04T00:00:00

Authors

Upadhayay, Shubham
Yedke, Narhari Gangaram
Rahi, Vikrant
Singh, Surbhi
Kumar, Sachin
Arora, Anchal
Chandolia, Priyanka
Kaur, Prabhsharan
Kumar, Mandeep
Koshal, Prashant

Journal Title

Journal ISSN

Volume Title

Publisher

Springer

Abstract

Animal models are used to better understand the various mechanisms involved in the pathogenesis of diseases and explore potential pathways that will aid in discovering therapeutic targets. 3-Nitropropionic Acid (3-NPA) is a neurotoxin used to induce Huntington's disease (HD)-like symptoms in experimental animals. The 3-NPA is a fungus toxin that impairs the complex II (succinate dehydrogenase) activity of the mitochondria and reduces ATP synthesis, leading to excessive production of free radicals resulting in the degeneration of GABAergic medium spiny neurons (MSNs) in the striatum. This is characterized by motor impairments a key clinical manifestation of HD. 3-NPA has the potential to alter several cellular processes, including mitochondrial functions, oxidative stress, apoptosis, and neuroinflammation mimicking HD-like pathogenic conditions in animals. This review strives to provide a new insight towards the 3-NPA induced molecular dysfunctioning in developing an animal model of HD. Moreover, we summarise several preclinical studies that support the use of the 3-NPA-induced models for drug discovery and development in HD. This review is a collection of various articles that were published from 1977 to 2022 on Pubmed (1639), Web of Science (2139), and Scopus (2681), which are related to the 3-NPA induced animal model. Graphical Abstract: [Figure not available: see fulltext.] � 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Description

Keywords

3-Nitropropionic acid (3-NPA), Animal Model, Huntington�s Disorder, Mitochondrial Dysfunction, Excitotoxicity, Neurodegeneration

Citation

Endorsement

Review

Supplemented By

Referenced By